Unlock instant, AI-driven research and patent intelligence for your innovation.

A disease detection kit comprising an antibody specifically binding to the AFP protein

A protein detection and kit technology, applied in the field of biomedicine, can solve the problems of non-specific binding and low sensitivity

Active Publication Date: 2020-11-17
深圳迈吉赛尔生物科技有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Based on the above findings, the primary purpose of the present invention is to provide a new AFP antibody that has higher sensitivity and does not react with HSA to solve the problem of low sensitivity of existing AFP antibodies and the possibility of non-specific binding to HSA

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A disease detection kit comprising an antibody specifically binding to the AFP protein
  • A disease detection kit comprising an antibody specifically binding to the AFP protein
  • A disease detection kit comprising an antibody specifically binding to the AFP protein

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1. Preparation and purification of anti-AFP antibody

[0020] After the AFP antigen (concentration of 1 µg / µl) was thoroughly mixed with an equal volume of complete Freund's adjuvant (CFA) to form a watery oil packet, BALB / C mice were initially immunized with 200 µl per mouse by intraperitoneal injection. After 3 weeks, the first boost was carried out. AFP antigen (concentration: 1 µg / µl) was mixed and emulsified with equal volumes of incomplete Freund's adjuvant (IFA), and injected into multiple points on the back, 200 µl per mouse. Thereafter, booster immunization was performed every 2 weeks, and the tail blood was collected on the 7th day after each immunization, and the antibody titer was detected by ELISA method. When the antibody titer reaches 10 -4 When left or right, mix and emulsify equal volumes of AFP antigen (concentration: 1 µg / µl) and incomplete Freund's adjuvant (IFA), and boost immunization once by multi-point injection on the back, 200 µl per m...

Embodiment 2

[0021] Example 2. Antibody and human serum albumin cross-reaction experiment

[0022] AFP protein has a high homology with human serum albumin and is prone to cross-reaction, which affects the specificity of AFP antibody. Therefore, cross-reaction experiments were used to screen out antibodies that do not cross-react with HAS. Add human serum albumin to the 96-well ELISA plate, 100 ng per well, and incubate overnight at 4°C. Remove the supernatant, add 200 μl of PBST washing solution to each well, let it stand for 2 minutes, deduct the washing solution, repeat the washing 3 times, and pat the microplate as dry as possible after each washing. Add bovine serum albumin and block for 1 h at 37°C. Remove the supernatant, add 200 μl PBST washing solution to each well, let it stand for 2 minutes, deduct the washing solution, and repeat washing 3 times. The antibodies prepared in Example 1 were added to the detection wells respectively, and incubated at 37° C. for 2 h. Remove the s...

Embodiment 3

[0025] Example 3. Competitive inhibition ELISA experiment

[0026]Since the establishment of a double-sandwich ELISA detection system requires two AFP antibodies that bind to different epitopes, the AFP antibodies that bind to different epitopes were screened by competitive inhibition ELISA experiments. The hAFP-6 antibody was labeled with horseradish peroxidase (HRP), which was used as an enzyme-labeled control antibody. Wherein the HRP labeling technique is well known in the art. hAFP-2, hAFP-3, and hAFP-5 were used as unlabeled antibodies to be tested. Add the AFP enzyme-labeled antibody to the 96-well enzyme-labeled plate coated with AFP antigen, and add different proportions of the antibody to be tested in the experimental group (antibody to be tested: enzyme-labeled antibody=1, 2, 4, 8, 16, 32 ), at the same time, set up a positive control of AFP enzyme-labeled antibody with PBS; incubate at 37°C for 1 hour; remove the supernatant, add 200 μl of PBST washing solution t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a disease detection kit containing an antibody specifically binding to AFP protein. The disease detection kit contains the antibody which can be specifically bound to AFP anddoes not cross-react with HAS. The kit has higher sensitivity and is used for early screening and diagnosis, curative effect detection and prognosis judgment of liver cancer with abnormal AFP and fetal congenital diseases.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a disease detection kit containing an antibody specifically binding to the AFP protein. Background technique [0002] Primary liver cancer is one of the malignant tumors with extremely poor prognosis. Currently, liver cancer ranks second in the mortality rate of malignant tumors in my country. Although liver cancer can be detected early and there are many treatment methods, the therapeutic effect is still unsatisfactory. Most patients with liver cancer have no significant effect on chemotherapy and radiotherapy, and only 15% of patients can be cured by surgery. Alpha-fetoprotein (alpha-fetoprotein, AFP) is an important tumor-associated antigen. At present, AFP is an important target antigen for the diagnosis and biological treatment of primary liver cancer. AFP is a fetal-specific protein, which is mainly synthesized in the fetal yolk sac and liver. It is a single-chain polypeptide a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/18G01N33/574
CPCC07K16/18C07K2317/565G01N33/57438
Inventor 史辛艺王阳金鑫
Owner 深圳迈吉赛尔生物科技有限公司